Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FUJRC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency on August 5, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract utilizes a firm fixed-price delivery order mechanism without a set-aside designation, with an ultimate completion date of August 6, 2025. This award represents a single delivery order executed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at approximately $500 million and valid through November 2026.
The DLA's SPE2DB program establishes a framework for issuing delivery orders covering a broad portfolio of pharmaceutical products to support medical supply needs across military healthcare facilities worldwide. Xtandi, an oncology medication, falls within the specialized pharmaceutical products that DMS Pharmaceutical Group regularly supplies to Department of Defense healthcare sites. As a consistent federal contractor with a robust track record of pharmaceutical deliveries to military health facilities, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and established distribution capabilities to fulfill government healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FUJRC?
SPE2DB25FUJRC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FUJRC worth?
The government has obligated $4,170 on SPE2DB25FUJRC.
Is contract SPE2DB25FUJRC an order under another contract?
Yes. SPE2DB25FUJRC is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRC competed?
The extent of competition for SPE2DB25FUJRC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award